All the news

Bluepharma presents R&D projects in the US

19.06.2015 in Bluepharma

From the 15th to the 18th June, Bluepharma was part of the Portuguese delegation at the BIO International Convention, held in the United States.

Bluepharma was in the United States introducing Research & Development projects to potential international investors and partners. BIO International Convention is the world’s largest biotechnology gathering and took place in Philadelphia, Pennsylvania, featuring more than 1,700 exhibitors.

The company is interested in out-licensing opportunities regarding its technologies: in the oncology field, currently at phase IIa clinical trials; as in oral thin films (OTF) – ultrathin films with the approximate size of a postage stamp, which immediately disintegrate in the mouth without water – a patient-centered technology that addresses specific needs. Additionally, Bluepharma offers out-licensing opportunities in the field of phase I clinical trials.

Integrating the Portuguese delegation at BIO International, Bluepharma took part in the Portugal’s Biotechnology Industry Organization (P-BIO) booth.